SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
4.345
-0.065 (-1.47%)
Jan 29, 2026, 3:13 PM EST - Market open
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $206.85 million as of January 29, 2026. Its market cap has increased by 512.37% in one year.
Market Cap
206.85M
Enterprise Value
105.73M
1-Year Change
512.37%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $206.85M, an increase of 58.20%. That is a compound annual growth rate of 9.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 209.95M | 17.91% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 220.51M |
| Inhibikase Therapeutics | 217.48M |
| Tiziana Life Sciences | 215.78M |
| Nuvectis Pharma | 214.40M |
| Crescent Biopharma | 209.77M |
| Arcturus Therapeutics Holdings | 209.41M |
| Alector | 208.48M |
| Camp4 Therapeutics | 207.52M |